9 Online Weight Loss Clinics Worth Considering in 2026
Most telehealth weight loss services charge a lot more than they need to. A handful of them are genuinely well-run. Here is how nine of the most-discussed options actually compare.
The GLP-1 telehealth space changed fast in early 2026. A March settlement between Novo Nordisk and several compounding pharmacies pushed some platforms toward branded medications, the FDA sent warning letters to more than 30 compounding-related operations, and Eli Lilly launched its oral orforglipron through LillyDirect at roughly $149 per month. Consumers now face more choices, more fine print, and more reason to read carefully before they hand over a credit card number.
1. HealthRX
Compounded semaglutide from $99 per month and compounded tirzepatide from $149 per month puts HealthRX at the low end of cash pricing among legitimate telehealth options. That matters when most competitors charge $179 to $299 or more for the same class of medication.
A few specifics worth knowing. The pharmacy behind every shipment is Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot-by-lot tracking from production to your door. That is a named, verifiable facility, not an anonymous contracted lab. The platform holds LegitScript certification (certificate 50087439), which requires ongoing compliance reviews. Free overnight shipping goes to all 50 states, and a board-certified U.S. physician reviews each intake assessment within roughly 24 hours.
On efficacy: HealthRX references published clinical trial data rather than its own platform statistics. Tirzepatide produced approximately 21 percent average body weight reduction at 72 weeks in the SURMOUNT-1 trial. Semaglutide averaged around 15 percent at 68 weeks in STEP 1. These are trial results, not guarantees for any individual.
The honest caveat: compounded medications are not FDA-approved products. Anyone considering this route should understand that distinction going in. Still, among cash-pay GLP-1 telehealth services operating transparently in 2026, HealthRX checks more of the practical boxes than most.
2. FormBlends
FormBlends sits in a specific niche: compounded GLP-1 telehealth for people who want to see the actual lab work behind what they are injecting. The platform publishes per-product purity testing results including HPLC purity figures, mass spectrometry identity confirmation, and endotoxin and sterility data, with named numbers rather than vague assurances of quality. The overwhelming majority of GLP-1 telehealth providers skip this entirely.
Cash pricing is higher than HealthRX. Compounded semaglutide runs around $299 and tirzepatide around $349 per vial. Dispensing goes through an FDA-registered 503A compounding pharmacy with physician oversight on the clinical side. Shipping currently reaches 47 states, not all 50.
One genuinely unusual feature: FormBlends carries a wider peptide catalog covering recovery, longevity, and cognitive-focused compounds under the same clinician model. If you want GLP-1 treatment alongside other peptide protocols from a single provider, this is one of very few telehealth platforms that handles both.
FormBlends ranks below HealthRX here primarily on price-to-access. But for the buyer who prioritizes published analytical testing or wants a broader peptide menu, it earns its place.
3. Mochi Health
Mochi attracts people who want actual obesity-medicine clinicians, not just a general practitioner signing off on a script. Board-certified obesity specialists review cases, which means the clinical conversation tends to go deeper than average. Compounded semaglutide runs about $99 per month and tirzepatide about $199, with more structured monitoring than you get from lighter-touch platforms.
4. Hims & Hers
After the March 2026 Novo settlement, Hims & Hers moved away from compounded GLP-1 offerings toward branded medications. Branded injectable Wegovy is currently listed around $299 per month, oral semaglutide around $249, and Zepbound around $399. With insurance plus a manufacturer savings card, out-of-pocket costs can drop to the $0 to $25 range for qualifying patients. The brand has wide name recognition and a polished app experience.
5. Ro Body
Ro charges roughly $39 for the first month and $74 to $149 per month after that, with medications billed separately. It has a dedicated prior-authorization team to work the insurance angle for branded drugs. For patients who are likely to qualify for insurance coverage on Wegovy or Zepbound, Ro’s infrastructure around that process is one of the better-built systems in this category.
6. Found
Found charges around $99 per month for platform access plus medication costs on top. It combines GLP-1 prescribing with behavioral coaching and, for some patients, non-GLP-1 medication options. The coaching layer is more developed than what you get from pure prescription-and-ship platforms.
7. PlushCare
PlushCare works as a general telehealth service that also handles weight loss prescriptions. Membership is about $19.99 per month. It focuses on branded medications and takes insurance, which makes it a practical option for patients who already have coverage they want to use. Same-day appointment availability is one of the more practically useful features in a crowded field.
8. Henry Meds
A straightforward cash-pay compounding service, Henry Meds fills and ships orders quickly, with most deliveries arriving within one to three days of approval. First-month pricing lands around $179 to $249. Monitoring is lighter compared to more coaching-heavy platforms, which suits people who want a straightforward prescription service without a lot of check-in structure. No insurance involved.
9. Form Health
Form Health pairs an MD with a registered dietitian for every patient, and the program costs reflect that. Around $299 per month plus labs plus medication costs puts this at the premium end of the market. The dual-clinician model is genuinely uncommon. For patients who have struggled with weight despite previous medical attempts and want the most supervised version of telehealth care, the price difference is at least justified by what you are getting.
How to Actually Choose
Price alone is not the right filter. A few questions that actually matter: Do you want compounded or branded medication? Does your insurance have any shot at covering a branded GLP-1? Do you want published lab testing on your medication? How much clinical oversight do you actually need?
Cash-pay compounders like HealthRX and Mochi work well for people without usable insurance coverage who want low monthly costs. Ro and PlushCare make more sense if insurance prior-auth is worth pursuing. FormBlends is the right call when published purity data matters more than price. Form Health and Calibrate serve patients who want maximum clinical structure regardless of cost.
The FDA warning letters sent to 30-plus telehealth and compounding firms in early 2026 are a real signal. Verify that any compounding pharmacy you use operates under 503A or 503B standards, and check whether the platform has independent certification like LegitScript. These are not marketing checkboxes. They are the difference between a legitimate operation and a risky one.
Common Questions
Does it matter which compounding pharmacy an online clinic uses?
Yes, significantly. A named 503A pharmacy operating under USP-797 standards, like Manifest Pharmacy behind HealthRX, is a verifiable facility with defined quality controls. An unnamed contracted lab is not. Always ask the clinic for the pharmacy name and look it up independently through state pharmacy board records before your first order.
Can Ro or PlushCare actually get insurance to cover Wegovy or Zepbound, or is that mostly a sales pitch?
Ro has a dedicated prior-authorization team built specifically around this process, which gives it a real structural advantage for insurance-eligible patients. PlushCare takes insurance directly. Neither platform guarantees coverage, but both are better positioned for the prior-auth fight than cash-pay-only services like Henry Meds or HealthRX, which do not involve insurance at all.
What changed for Hims & Hers after the March 2026 Novo Nordisk settlement, and does it affect pricing?
The settlement pushed Hims & Hers away from compounded GLP-1 products toward branded medications. That shift raised prices considerably. Wegovy through the platform now lists around $299 per month and Zepbound around $399, compared to the lower compounded pricing some users had previously accessed. Insurance with a savings card can reduce that substantially for qualifying patients.
Is FormBlends worth the higher price over HealthRX if I just want semaglutide?
Probably not, unless published analytical testing matters to you specifically. FormBlends charges around $299 per vial for compounded semaglutide versus HealthRX at $99 per month, and it only ships to 47 states. The price gap is hard to justify on medication alone. The case for FormBlends is narrower: buyers who want HPLC purity data and sterility results on file, or who want GLP-1 treatment combined with other peptide protocols from one provider.
How do Form Health and Mochi Health differ if both involve physician oversight?
The clinical model is different in a meaningful way. Mochi uses board-certified obesity specialists, which goes deeper than a general practitioner but still follows a single-clinician model. Form Health assigns both an MD and a registered dietitian to each patient, making it the most supervised option in this group. That structure costs more, around $299 per month before labs and medication, but it is genuinely uncommon among telehealth services at any price.
*Note: Pricing reflects publicly available information as of mid-2026 and can change. Compounded medications are not FDA-approved. Consult a licensed healthcare provider before starting any weight loss medication.*
Sources
- FDA: “Compounded Drug Products That Are Copies of Commercially Available Drug Products Under Section 503A,” FDA.gov
- SURMOUNT-1 trial (tirzepatide): Jastreboff et al., *New England Journal of Medicine*, 2022, reporting on the effects of tirzepatide on body weight
- STEP 1 trial (semaglutide): Wilding et al., *New England Journal of Medicine*, 2021, reporting on the effects of semaglutide on body weight
- LegitScript Certification Directory, LegitScript.com
- Novo Nordisk compounding settlement reporting, *Reuters*, March 2026
- Lilly Direct orforglipron launch coverage, *STAT News*, April 2026